• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROVENTION INC WEB ANEURYSM EMBOLIZATION SYSTEM; INTRASACCULAR FLOW DISRUPTION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROVENTION INC WEB ANEURYSM EMBOLIZATION SYSTEM; INTRASACCULAR FLOW DISRUPTION DEVICE Back to Search Results
Model Number W5-5-2-MVI-3
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Intracranial Hemorrhage (1891)
Date of Event 01/28/2025
Type of Reportable Event Serious Injury
Event or Problem Description
As reported through the clinical study web pas: event #: 4 ae description: on pod 204 ¿follow up mr imaging demonstrated interval treatment of anterior communicating artery aneurysm with a web device.Suspect 3 x 1 mm focus of residual aneurysmal flow along the left anterior aspect of the web device.Presumed tiny microhemorrhages in left cerebellum and right anterior frontal lobe.Recommend correlation with mri of the brain.Mri brain without gad on (b)(6) 2025 demonstrated tiny susceptibility artifacts are again seen within the left cerebellum and right posterior and anterior inferior right parasagittal frontal lobe, likely a sequela of prior microbleeds.¿ event term: follow up imaging mra.Event start date: 28-jan-2025.Was this a serious ae? no.Was the ae caused by or associated with a technical event? : no.Relationship to study device: not related.Relationship to index endovascular procedure: not related.Relationship to use of ancillary device: not related.Relationship to study disease: not related.Relationship to concomitant disease: probable.Ae outcome: recovered/resolved.Recovered/resolved: date of resolution: (b)(6) 2025.Relationship to study device: possible.Relationship to study procedure: not related.Information received notes the images mentioned are not available for return/review.It is noted the issue resolved on (b)(6) 2025.No other information was provided.
 
Additional Manufacturer Narrative
Investigation findings: based on a review of the device¿s risk documentation, the reported event did not indicate there were the presence of any potential or new manufacturing, design, quality, or other systemic issues, or non-conformances.The complaint code is monitored through the trending process; corrective action is determined, as needed, through this process.Investigations of historic complaint files with similar complaint category coding are recorded in the complaint handling system; without the ability to perform an analysis of the device, this investigation cannot identify with certainty any potential root causes.Batch review: a search for non-conformances associated with this part/lot number combination did not reveal any production-related issues relevant to the complaint that occurred during manufacturing of the device.Complaint system review: there are two (2) complaints from the last 2 years recorded in the complaint handling system with this batch number at the time of this investigation.Based on a review of the last 2 years of complaint data, and at the time of this investigation, no systemic issues have been identified for this batch number that would have caused or contributed to the reported event.Ifu review (additional information can be found in the ifu): potential complications.Potential complications include but are not limited to the following: vessel puncture site hematoma, aneurysm perforation or rupture, hemorrhage, edema, thromboemboli, transient ischemic attack, ischemic stroke, neurologic deficits, parent artery occlusion, ischemia, vessel dissection or perforation, vascular thrombosis, vasospasm, device migration or misplacement, premature detachment, headache, post-embolization syndrome, infection and death.Warnings: advance and retract the web embolization device slowly.Do not advance the delivery device with excessive force.Determine the cause of any unusual resistance.Remove the web embolization device if excessive friction is noted and check for damage.Do not rotate the delivery device during or after delivery of the web embolization device.Rotating the web embolization device may result in damage or premature detachment.The web embolization device cannot be detached with any other power source other than a web detachment control device.Ensure that at least two web detachment control devices are available before initiating an embolization.Procedure - instructions for use.Detachment of the web embolization device.34.The detachment control device is pre-loaded with batteries and will activate when the delivery device is properly connected.35.Verify that the rhv is firmly locked around the delivery device before attaching the detachment control device to ensure that the web embolization device does not move during the connection process.36.Ensure that the delivery device gold connectors are clean and free from blood or contrast.If necessary, wipe the connectors with sterile water and dry before connecting.37.Insert the proximal end of the delivery device into the detachment control device.When the delivery device is properly connected, the light will flash green and an intermittent tone will be heard.38.Verify the web embolization device position before pressing the detachment button.39.Push the detachment button.During firing, the light should be solid green and the beep should be continuous.40.Verify detachment by first loosening the rhv valve, then pulling back slowly on the delivery device and verifying that there is not web embolization device movement.If the web embolization device does not detach, push the detachment button again.If the web embolization device is still not detached, obtain a new detachment control device and attempt detachment up to two additional times.If it does not detach, remove the delivery device.41.Verify the position of the web embolization device angiographically through the guide catheter.42.Prior to removing the microcatheter from the treatment site, place an appropriately sized guidewire completely through the microcatheter lumen to ensure that no part of the web embolization device remains within the microcatheter.Investigation conclusion: the physical device was not available for evaluation to investigate if a condition existed that would have contributed to the reported event.Supplemental imaging was also unavailable for review; without imaging, the investigation cannot verify the event occurred as described, nor could the investigation further examine the cause of the reported event.This information may be updated if additional information is provided at a later date.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WEB ANEURYSM EMBOLIZATION SYSTEM
Common Device Name
INTRASACCULAR FLOW DISRUPTION DEVICE
Manufacturer (Section D)
MICROVENTION INC
35 enterprise
aliso viejo CA 92656
Manufacturer (Section G)
MICROVENTION INC
35 enterprise
aliso viejo CA 92656
Manufacturer Contact
terrence callahan
35 enterprise
aliso viejo, CA 92656
7142478000
MDR Report Key22145165
Report Number2032493-2025-90226
Device Sequence Number18274280
Product Code OPR
UDI-Device Identifier00842429110843
UDI-Public(01)00842429110843(11)240318(17)270228(10)0000543966
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
P170032
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Study
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 06/04/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberW5-5-2-MVI-3
Device Lot Number0000543966
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/16/2025
Initial Report FDA Received Date06/04/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured03/18/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-